Stephens Inc. AR Has $759,000 Stock Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Stephens Inc. AR boosted its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 17.3% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 29,061 shares of the pharmacy operator’s stock after buying an additional 4,290 shares during the period. Stephens Inc. AR’s holdings in Walgreens Boots Alliance were worth $759,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Highlander Capital Management LLC bought a new position in shares of Walgreens Boots Alliance during the fourth quarter worth approximately $26,000. Venturi Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 1,241.8% during the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 981 shares during the period. Rocky Mountain Advisers LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. Quest Partners LLC bought a new position in Walgreens Boots Alliance in the fourth quarter valued at approximately $30,000. Finally, 1832 Asset Management L.P. increased its stake in Walgreens Boots Alliance by 282.1% in the fourth quarter. 1832 Asset Management L.P. now owns 1,219 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 900 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Insider Transactions at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan bought 6,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 2nd. The shares were acquired at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the completion of the acquisition, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In other news, Director Inderpal S. Bhandari bought 3,000 shares of the company’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, for a total transaction of $54,150.00. Following the completion of the acquisition, the director now directly owns 3,000 shares in the company, valued at $54,150. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Manmohan Mahajan bought 6,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 2nd. The stock was purchased at an average price of $19.38 per share, for a total transaction of $116,280.00. Following the acquisition, the chief financial officer now owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The disclosure for this purchase can be found here. 17.40% of the stock is owned by company insiders.

Walgreens Boots Alliance Price Performance

Shares of NASDAQ:WBA opened at $15.94 on Tuesday. The firm has a market cap of $13.75 billion, a PE ratio of -2.28, a price-to-earnings-growth ratio of 0.99 and a beta of 0.78. The firm’s fifty day moving average is $17.36 and its 200-day moving average is $20.76. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance, Inc. has a 52 week low of $14.62 and a 52 week high of $32.89.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 EPS for the quarter, topping analysts’ consensus estimates of $0.82 by $0.38. The company had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a negative net margin of 4.18% and a positive return on equity of 12.11%. Walgreens Boots Alliance’s revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.16 earnings per share. Sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 3.21 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Tuesday, May 21st will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 6.27%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.29%.

Analyst Ratings Changes

A number of brokerages recently issued reports on WBA. HSBC reissued a “reduce” rating and issued a $20.00 price objective (down from $27.00) on shares of Walgreens Boots Alliance in a research note on Tuesday, February 20th. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating on the stock in a research note on Wednesday, April 3rd. UBS Group decreased their price objective on shares of Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 3rd. Truist Financial restated a “hold” rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a research report on Monday, April 1st. Finally, Morgan Stanley cut their target price on shares of Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating on the stock in a research report on Friday, May 31st. Four analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus price target of $23.57.

Check Out Our Latest Stock Analysis on WBA

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

See Also

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.